Hinrich J. Abken, M.D., Professor, Internal Medicine I, University of Cologne
Gyorgy Babnigg, Ph.D., Scientist, Biological Sciences, Argonne National Laboratory
Clare Baecher-Allan, Ph.D., Assistant Professor of Neurology, Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School
Patrick Baeurle, Ph.D., CSO & Senior Vice President, R&D, Micromet
Carlos F. Barbas III, Ph.D., Kellogg Professor, The Skaggs Institute for Chemical Biology, Department of Chemistry, The Scripps Research Institute
Robin Barbour, Ph.D., Associate Director, Biology, Elan Pharmaceuticals
Stefan Barth, Ph.D., Department of Pharmaceutical Product Development, Fraunhofer IM
Erik A. Bateman, Ph.D., Research Associate Professor, Microbiology & Molecular Genetics, University of Vermont
Alain Beck, Ph.D., Head of Department, Physico-Chemistry, Institut de Recherche Pierre Fabre
Barend Bouma, Ph.D., COO & Head, R&D, Crossbeta Biosciences
William J. Breslin, Ph.D., Senior Research Advisor, NSD Safety Assessment, Eli Lilly and Company
Sara J. Brett, Ph.D., Department of Immunology, GlaxoSmithKline
Vladimir Brusic, Ph.D., Director, Bioinformatics, Cancer Vaccine Center, Dana-Farber Cancer Institute
Eric Campeau, Ph.D., Program in Gene Function and Expression, University of Massachusetts Medical School
Shawn Cao, Ph.D., Principal Scientist, Process and Product Development, Amgen, Inc.
Bruce Carpick, Ph.D., Principal Scientist, Biochemistry Research, Sanofi Pasteur
Mark Carvlin, Ph.D., COO, CardioVax
Gerald Casperson, Ph.D., Associate Research Fellow, Biotherapeutics, Pfizer Global Research & Development
Joy Cavagnaro, Ph.D., President, Access BIO
Ravi V. Chari, Ph.D., Executive Director, Chemistry & Biochemistry, ImmunoGen, Inc.
Daniel Christ, Ph.D., Senior Lecturer, Garvan Institute of Medical Research; Senior Lecturer (conj.), Faculty of Medicine, The University of New South Wales
Janet Clarke, Ph.D., D.A.B.T., Senior Director, Pharmacotoxicology, Biogen Idec
Adrienne Clements-Egan, Ph.D., Principal Research Scientist, Biologics Clinical Pharmacology, Johnson & Johnson
Jennifer Cochran, Ph.D., Assistant Professor, Bioengineering, Stanford Medical Center
Jacques Descotes, M.D., Pharm.D., Ph.D., Fellow ATS, Professor and Head, Poison Center and Pharmacovigilance Department, Lyon University Hospitals
Nazzareno Dimasi, Ph.D., Scientist II, Antibody Discovery & Protein Engineering, MedImmune
Benjamin Doranz, Ph.D., President and CSO, Integral Molecular
Stefan Dübel, Ph.D., Professor, Technical Institute of Braunsweig
Jeffrey A. Engelhardt, D.V.M., Ph.D., DACVP, President and Pathologist, Engelhardt Consulting, Inc., and SNBL USA, Ltd.
Andrew Erdman, M.D., Global Safety Medical Director, Amgen
Dominic Esposito, Ph.D., Group Leader, Clone Optimization Group, Protein Expression Laboratory, Advanced Technology Program, SAIC-Frederick, Inc.Michael J. Feldhaus, Ph.D., Senior Director, Antibody Engineering, Adimab, Inc.
Tia Estey, Ph.D., Scientist II, Protein Pharmaceutical, Development, Biogen-Idec
S. Edwin Fineberg, M.D., Emeritus Professor of Medicine and Endocrinology, Indiana University School of Medicine; Clinical Professor of Medicine, University of Alabama School of Medicine
Nicolas Fischer, Ph.D., Head of Protein Engineering, NovImmune SA
Kevin FitzGerald, Ph.D., MBA, CEO, f-star GmbH
Christian Freund, Ph.D., Principal Investigator/Group leader, Structural Biology, FMP/Free University of Berlin
Rachel Friedman Ohana Ph.D., Senior Research Scientist, Research and Development: Cellular Proteomics, Promega Corporation
Georgeen Gaza-Bulseco, M.S., Senior Research Scientist, Abbott Bioresearch Center
Christoph Giese, Ph.D., Director, Cell and Tissue Services, ProBiogen
Christoph Geisel, Department of Molecular Biology, University of Wyoming
George Georgiou, Ph.D., Professor, Chemical Engineering, University of Texas, Austin
Arnout Gerritsen, Genmab, Netherlands
Pierre-Alain Girod, Ph.D., CSO, Selexis S.A.
Yatin Gokarn, Ph.D., Associate Director, Late-stage Pharmaceutical and Process Development, Genentech
Rui Gong, Ph.D., Postdoctoral Visiting Fellow, Protein Interaction Group, CCRNP, CCR, NCI-Frederick
Scott Gridley, Ph.D., Head of Product Development, Blue Sky Biotech
Paul Hamblin, Ph.D., Manager, Discovery Biopharm, GlaxoSmithKline
Christian Heinis, Ph.D., Professor, Laboratory of Therapeutic Peptides & Proteins, Ecole Polytechnique Fédéral de Lausanne (EPFL)
Carl “Charlie” Hitscherich Jr., Ph.D., Associate Director, Protein Pharmaceutical Development, Biogen Idec
Mitchell Ho, Ph.D., Head, Antibody Therapy Unit, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health (NIH)
Min Huang, Ph.D., Principal Scientist, Pharmaceutical Research and Development, Global Biologics, Pfizer, Inc.
Peter Hudson, Ph.D., CSO, Avipep Laboratories, Avipep Pty, Ltd.
John Iacomini, Ph.D., Associate Professor of Medicine, Assistant Director, Scientific Affairs, Transplantation Research Center, Brigham and Women’s Hospital and Children’s Hospital Boston, Harvard Medical School
Vibha Jawa, Ph.D., Senior Scientist, Clinical Immunology, Amgen
Roy Jefferis, Ph.D., Professor of Molecular Immunology University of Birmingham, Division of Immunity & Infection
Devendra (Davy) S. Kalonia, Ph.D., Professor of Pharmaceutics, University of Connecticut
Igor A. Kaltashov, Ph.D., Associate Professor, Department of Chemistry, University of Massachusetts, Amherst
David King, Ph.D., Vice President, Research, Anaptys Bio
Lindsay King, Ph.D., Senior Principal Scientist, PDM Regulated Biotherapeutics, Pfizer, Inc.
Joost Kolkman, Ph.D., Associate Director, Discovery, Ablynx
Roland Kontermann, Ph.D., Professor, Biomedical Engineering, Institute of Cell Biology & Immunology, University of Stuttgart
Robert J. Kreitman, Ph.D., Principal Investigator, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health
Bing Kuang, Ph.D., Principal Scientist, Pharmacokinetics, Pharmacodynamics, and Metabolism, Pfizer, Inc.
Jeremy P. Kunkel, Ph.D., Research Scientist, Centre for Biologics Research, Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada
Jonathan R. Lai, Ph.D., Assistant Professor, Department of Biochemistry, Albert Einstein College of Medicine
Philip Laible, Ph.D., Argonne National Laboratory
Thomas M. Laue, Ph.D., Professor, Biochemistry and Molecular Biology; Director, Biomolecular Interaction Technologies Center (BITC), University of New Hampshire
Jean-Luc Lenormand, Ph.D., HumProTher Laboratory, Université Joseph Fourier
Wei Liao, Ph.D., Senior Research Scientist, Project Team Leader, BioTherapeutic Center of Emphasis, Pfizer, Inc.
Li Lin, Ph.D., Cardiovascular Sciences, National Institute on Aging, NIH
Horst Lindhofer, Ph.D., Founder & CEO, Trion Pharma GmbH
A. James Link, Ph.D., Professor, Chemical Engineering & Molecular Biology, Princeton University
David Litzinger, Ph.D., Director, Pharmaceutical Sciences, Amylin Pharmaceuticals, Inc.
David Lowe, Ph.D., Head, Display Technology, RI & A, MedImmune, Inc.
Alexey Lugovskoy, Ph.D., Head of Molecular Modeling and NMR, Drug Discovery, Biogen IDEC, Inc.
Peter Luo, Ph.D., Director, Biologics, Merck & Co., Inc.; CTO, Abmaxis, Inc., A wholly owned subsidiary of Merck & Co., Inc.
Lawrence G. Lum, M.D., DSc, Professor Medicine, Professor of Immunology and Microbiology, Scientific Director of Immunotherapy and BMT, Barbara Ann Karmanos Cancer Institute
Carmel Lynch, Ph.D., Senior Director, Nonclinical Science & Clinical Pharmacology, Seattle Genetics
Shengwu Ma, Ph.D., Plantigen Inc.; University of Western Ontario
Henryk Mach, Ph.D., Senior Investigator, Bioprocess Analytical and Formulation Sciences, Merck Research Laboratories
Kevin Mattison, Ph.D., Senior Bioanalytical Scientist, Research & Development, Malvern Instruments Ltd.
Marco Muda, Ph.D., Binders & Protein Engineering, EMD Serono Research Institute, Inc.
Jennifer Nemeth, Ph.D., Principal Research Scientist, Biologics Research, Centocor Research and Development
Jeffrey L. Nordstrom, Ph.D., Director, Product Development Research, MacroGenics, Inc.
Victor H. Obungu, Ph.D., Senior Research Scientist, Biotechnology Discovery Research, Eli Lilly and Company
Shane Olwill, Ph.D., Director, Research & Development, Fusion Antibodies Ltd.
Ira Pastan, Ph.D., Head, Molecular Biology Section, NCI, NIH
Blaine A. Pfeifer, Assistant Professor, Chem. & Biological Eng., Tufts University
Tatiana Plavina, Ph.D., Scientist, Clinical Science & Technology, Biogen Idec
Mark Pollo, Associate Senior Biophysical Chemist, Bioproduct Research & Development, Eli Lilly and Comapny
Julia Ponomarenko, Ph.D., Senior Scientist, Computational Biology, Skaggs School of Pharmacy & Pharmaceutical Science, San Diego Supercomputer Center, University of California, San Diego
Jaume Pons, Ph.D., Vice President & CSO, Research, Rinat Pfizer
Alfred S. Ponticelli, Ph.D., Associate Professor, Biochemistry, School of Medicine and Biomedical Sciences, State University of New York, Buffalo
James Prudent, Ph.D., CEO, Research & Development, Centrose LLC
Wendy Putnam, Ph.D., Scientist, Pharmacokinetics and Pharmacodynamics, Genentech, Inc.
Julia Qiu, Ph.D., Scientist, Bioanalytical Research & Development, Genentech, Inc.
Lata Ramanathan, Ph.D., Senior Scientist, Protein Sciences, Schering-Plough Research Institute
Vangipuram Rangan, Ph.D., Director, Protein Chemistry, Medarex, a wholly owned subsidiary of Bristol-Myers Squibb Co.
Balaji Rao, Ph.D., Assistant Professor, Chemical Engineering, North Carolina State University
Birgit Reipert, Ph.D., Director, R&D, Department of Immunology, Baxter
Joel Richard, Ph.D., Senior Director, Head of Drug Product Development, Pharmaceutical Development, Ipsen
Stanley A. Roberts, Ph.D., Vice President, Pre-Clinical Development, CovX Research LLC, a subsidiary of Pfizer, Inc.
Ankita Roy, Ph.D., NIEHS, NIH
Pauline Rudd, B.Sc., LRIC, MA (OXON), Ph.D., NIBRT Professor, Glycobiology, University College Dublin, Medical Sciences, NIBRT
Justin M. Scheer, Ph.D., Scientist, Protein Chemistry, Genentech, Inc.
Huub Schellekens, M.D., Ph.D., Department of Pharmaceutical Sciences, Department of Innovation Studies, Utrecht University
Thomas Schirrmann, Ph.D., Senior Scientist, Institute of Biochemistry and Biotechnology, Technische Universität Braunschweig
Birgit Schoeberl, Ph.D., Vice President, Discovery, Merrimack Pharmaceuticals
Diane Seimetz, Ph.D., CSO, Executive Vice President, Drug Development, Fresenius Biotech
Alessandro D. Sette, Ph.D., Principal Investigator, Vaccine Discovery, La Jolla Institute for Allergy & Immunology
Harold Michael Shepard, Ph.D., Vice President, Discovery Research, Halozyme Therapeutics, Inc.
Eric V. Shusta, Ph.D., Assistant Professor, Chemical & Biological Engineering, University of Wisconsin, Madison
Ernest S. Smith, Senior Vice President, Research, CSO, Vaccinex, Inc.
Holly W. Smith, Ph.D., Senior Research Scientist, Investigative Toxicology, Eli Lilly and Company
Franklin Spriggs, Ph.D., Scientist, PDM, Pfi zer Global R&D Groton Labs
Nancy Stagliano, Ph.D., CEO, CytomX Therapeutics, LLC
Dinica Stanimirovic, M.D., Ph.D., Director, Neurobiology, National Research Council, Canada
Jennitte Stevens, Ph.D., Senior Scientist, Protein Science, Amgen
James R. Swartz, Ph.D., Bioengineering, Stanford University
Marque Todd, Ph.D., Regulatory Strategy Lead, Drug Safety Research & Development, Pfizer, Inc.
Inna Vainshtein, Ph.D., Scientist II, Global PK-PD & Bioanalysis, MedImmune
Daniela Verthelyi, Ph.D., Acting Chief, Laboratory of Immunology, DTP/FDA
Meenu Wadhwa, Ph.D., Head, Cytokines & Growth Factors & Biotherapeutics, National Institute for Biological Standards and Control
Eric Wakshull, Ph.D., Senior Scientist & Group Leader, Bioanalytical Research & Development Department, Genentech, Inc.
Thomas Waldmann, Ph.D., Director, Science & Technology Support, Sloning BioTechnology GmbH
Geoffrey Waldo, Ph.D., Team Leader, Biosciences, Los Alamos National Laboratories
James A. Wells, Ph.D., Department of Pharmaceutical Chemistry, University of California, San Francisco
John Wheeler, Ph.D., Senior Research Scientist, Biologics Research, Centocor
Robert T. Woodland, Ph.D., Department of Molecular Genetics & Microbiology, University of Massachusetts Medical School
Gary Woodnutt, Ph.D., Vice President, Biology, CovX Pharmaceuticals, Inc., Pfizer, Inc.
Bingyuan Wu, Ph.D., Research Scientist, Molecular and Protein Biosciences, Centocor, Inc.
Herren Wu, Ph.D., Vice President, Antibody Discovery & Protein Engineering, MedImmune
Sam Wu, Ph.D., Senior Research Scientist, Biologics Research, Centocor R&D, Inc.
Wen Jin Wu, Ph.D., Principal Investigator, Division of Monoclonal Antibodies, OBP/OPS/CDER, Food and Drug Administration
Hai Yan, Ph.D., Scientific Director, Protein Science, Amgen, Inc.
Jihong Yang, Ph.D., Scientist, Bioanalytical Research & Development, Genentech, Inc.
Liang Zhao, Ph.D., Associate Director, Global PK-PD & Bioanalysis, MedImmune
Qinjian Zhao, Ph.D., Distinguished Senior Investigator, Bioprocess Analytical and Formulation Sciences, Merck Research Laboratories, Merck & Co., Inc.
Zhenping Zhu, M.D., Ph.D., Vice President & Global Head, Protein Sciences & Design, Novartis Biologics
Jesús Zurdo, Ph.D., Head, Advanced Protein Technologies, Lonza Biologics plc